| Passive transfer of fibromyalgia symptoms from patients to mice A Goebel, E Krock, C Gentry, MR Israel, A Jurczak, CM Urbina, K Sandor, ... The Journal of clinical investigation 131 (13), 2021 | 153 | 2021 |
| NaV1. 7 as a pain target–from gene to pharmacology I Vetter, JR Deuis, A Mueller, MR Israel, H Starobova, A Zhang, LD Rash, ... Pharmacology & therapeutics 172, 73-100, 2017 | 135 | 2017 |
| Animal toxins—Nature’s evolutionary-refined toolkit for basic research and drug discovery V Herzig, B Cristofori-Armstrong, MR Israel, SA Nixon, I Vetter, GF King Biochemical pharmacology 181, 114096, 2020 | 122 | 2020 |
| Multiple sodium channel isoforms mediate the pathological effects of Pacific ciguatoxin-1 MC Inserra, MR Israel, A Caldwell, J Castro, JR Deuis, AM Harrington, ... Scientific reports 7 (1), 42810, 2017 | 83 | 2017 |
| The pharmacology of voltage-gated sodium channel activators JR Deuis, A Mueller, MR Israel, I Vetter Neuropharmacology 127, 87-108, 2017 | 72 | 2017 |
| Sodium channels and venom peptide pharmacology MR Israel, B Tay, JR Deuis, I Vetter Advances in pharmacology 79, 67-116, 2017 | 62 | 2017 |
| Australian funnel-web spiders evolved human-lethal δ-hexatoxins for defense against vertebrate predators V Herzig, K Sunagar, DTR Wilson, SS Pineda, MR Israel, S Dutertre, ... Proceedings of the National Academy of Sciences 117 (40), 24920-24928, 2020 | 42 | 2020 |
| NaV1.6 regulates excitability of mechanosensitive sensory neurons MR Israel, BS Tanaka, J Castro, P Thongyoo, SD Robinson, P Zhao, ... The Journal of Physiology 597 (14), 3751-3768, 2019 | 40 | 2019 |
| δ-Conotoxin SuVIA suggests an evolutionary link between ancestral predator defence and the origin of fish-hunting behaviour in carnivorous cone snails AH Jin, MR Israel, MC Inserra, JJ Smith, RJ Lewis, PF Alewood, I Vetter, ... Proceedings of the Royal Society B: Biological Sciences 282 (1811), 20150817, 2015 | 35 | 2015 |
| Neurotoxic peptides from the venom of the giant Australian stinging tree EK Gilding, S Jami, JR Deuis, MR Israel, PJ Harvey, AG Poth, FBH Rehm, ... Science advances 6 (38), eabb8828, 2020 | 21 | 2020 |
| Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7 AJ Agwa, P Tran, A Mueller, HNT Tran, JR Deuis, MR Israel, KL McMahon, ... Journal of Biological Chemistry 295 (15), 5067-5080, 2020 | 21 | 2020 |
| The E15R Point Mutation in Scorpion Toxin Cn2 Uncouples Its Depressant and Excitatory Activities on Human NaV1.6 MR Israel, P Thongyoo, JR Deuis, DJ Craik, I Vetter, T Durek Journal of medicinal chemistry 61 (4), 1730-1736, 2018 | 12 | 2018 |
| Characterization of Synthetic Tf2 as a NaV1.3 Selective Pharmacological Probe MR Israel, TS Dash, SN Bothe, SD Robinson, JR Deuis, DJ Craik, ... Biomedicines 8 (6), 155, 2020 | 9 | 2020 |
| Toxins as tools: Fingerprinting neuronal pharmacology MR Israel, M Morgan, B Tay, JR Deuis Neuroscience Letters 679, 4-14, 2018 | 9 | 2018 |
| Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function S Jami, JR Deuis, T Klasfauseweh, X Cheng, S Kurdyukov, F Chung, ... Nature Communications 14 (1), 2442, 2023 | 6 | 2023 |
| Low potency inhibition of NaV1. 7 by externally applied QX-314 via a depolarizing shift in the voltage-dependence of activation T Klasfauseweh, MR Israel, L Ragnarsson, JJ Cox, T Durek, DA Carter, ... European Journal of Pharmacology 925, 175013, 2022 | 1 | 2022 |
| Topical oxaliplatin produces gain-and loss-of-function in multiple classes of sensory afferents N Saleque, N Vastani, C Gentry, DA Andersson, MR Israel, S Bevan The Journal of Pain 25 (1), 88-100, 2024 | | 2024 |
| Elucidating the role of NaV1. 6 in peripheral sensory neurons MR Israel | | 2019 |
| B) Manipulating the pharmacophore of HwTx-IV to influence affinity for lipid bilayers, and in vitro selectivity for NaV1. 7 AJ Agwa, A Mueller, MR Israel, P Tran, DJ Craik, I Vetter, CI Schroeder The tri-molecular concept: exploiting the lipid membrane in the design of …, 0 | | |
